Brief: Coree Announces Discovery Of Microbiome Biomarkers Specific To Diabetes And Obesity Patients
26/09/2025 14:14
Sept 26 (Reuters) - Dx & Vx Co Ltd 180400.KQ: COREE ANNOUNCES DISCOVERY OF MICROBIOME BIOMARKERS SPECIFIC TO DIABETES AND OBESITY PATIENTS Source text: ID:nPnbyss2pa Further company coverage: 180400.KQ ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dx & Vx
See all newsBrief: Coree Announces Discovery Of Microbiome Biomarkers Specific To Diabetes And Obesity Patients
Development And License Agreement For Mrna Cancer Vaccine With U.S. Biotech Company
Brief: Dx&Vx Accelerates Development of Universal COVID-19 Vaccine
Slovenia's parliament commission rejects former prime minister as central bank governor
Brief: Dx & Vx Co Ltd Wins 10.3 Billion Won Order